Xuan Hong

1.0k citations
36 papers · 750 indexed · h-index 15
Topics
Lung Cancer Research Studies (8 papers)Lung Cancer Treatments and Mutations (6 papers)MicroRNA in disease regulation (3 papers)
Partner nations
ChinaUnited StatesItaly

In The Last Decade

Xuan Hong

33 papers receiving 740 citations

Peers

Xuan Hong
Comparison fields: 5 of 89
  • Oncology 394
  • Molecular Biology 286
  • Cancer Research 220
  • Pulmonary and Respiratory Medicine 164
  • Epidemiology 83
Replace Xianghua Yi with:
Xianghua Yi China
Qiu‐Fang Gao China
Ying Tian China
Chengzeng Yin Japan
Kohei Horioka Japan
Shubin Song China
Meral Günaldı Türkiye
Pranav Murthy United States
Anna M. Leung United States
Xuan Hong relative to Xianghua Yi China Xianghua Yi's profile →
Citations per field
00.5×1.5×2.4×
Xianghua Yi · 1×
Citations per year

Countries citing papers authored by Xuan Hong

Since Specialization
Citations

This map shows the geographic impact of Xuan Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuan Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuan Hong more than expected).

Fields of papers citing papers by Xuan Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuan Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuan Hong. The network helps show where Xuan Hong may publish in the future.

Co-authorship network of co-authors of Xuan Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Xuan Hong. A scholar is included among the top collaborators of Xuan Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuan Hong. Xuan Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 1
5 1
6 6
7 1
8 8
9 21
10 82
11 29
12 14
13 45
14 4
15 24
16 18
17 17
18 9
19 33
20
[Establishment of a multi drug-resistant human lung adenocarcinoma cell line and biological characteristics there of].
3

About Xuan Hong

Xuan Hong is a scholar working on Cancer Research, Oncology and Anesthesiology and Pain Medicine, having authored 36 papers that have together received 750 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (8 papers), Lung Cancer Treatments and Mutations (6 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (220 citations), Oncology (394 citations) and Pulmonary and Respiratory Medicine (164 citations). Xuan Hong has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Zhaoyang Yang, Baohong Cui, Meng Wang, Qingyong Xu, Li Wang, Meng Wang, Fang� Yang, Leiguang Ye, Yina Gao and Baogang Liu. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Journal of Agricultural and Food Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026